ABRYSVO

Indicated For

Respiratory Syncytial Virus (RSV) prevention in infants

About This Medication

# Pfizer RxPathways Patient Guide: How to Get ABRYSVO (Respiratory Syncytial Virus Vaccine (RSVpreF)) at Low or No Cost ABRYSVO is a respiratory syncytial virus (RSV) vaccine from Pfizer designed to protect adults aged 60 and older, and certain pregnant individuals, from severe RSV disease. Pfizer RxPathways offers support for uninsured and underinsured patients to access this vaccine through insurance reimbursement or patient assistance, making it low or no cost for eligible individuals.[1][2] ## About ABRYSVO **ABRYSVO** (RSVpreF) is an FDA-approved vaccine that helps prevent lower respiratory tract disease caused by RSV. RSV is a common virus that can lead to serious illness, especially in older adults and infants born to vaccinated pregnant women. The vaccine is typically a single dose administered by a healthcare provider in an outpatient setting.[1][6] This guide explains how Pfizer RxPathways can help you get ABRYSVO if cost is a barrier. The program reimburses nearly all commercial and Medicaid claims and provides assistance for those without adequate coverage.[program details] ## Who Qualifies for Pfizer RxPathways? Eligibility focuses on uninsured or underinsured patients (government insurance like Medicaid may qualify, but commercial insurance typically does not for free medicine).[2][3] Key requirements include: - Living in the US, Puerto Rico, or US Virgin Islands. - Treated by a licensed US healthcare provider in an outpatient setting. - Prescription for an FDA-approved use. - Meeting income guidelines (for vaccines, generally at or below **300% of the Federal Poverty Level (FPL)**, adjusted for household size).[1][6] **Commercially insured patients** are generally not eligible for free medicine but may have claims reimbursed.[program details][2] ## Income Eligibility Breakdown For ABRYSVO assistance via Pfizer's Patient Assistance Program (PAP), household income must be at or below **300% FPL** (pre-tax annual income).[1] Use the table below based on current guidelines (check aspe.hhs.gov for updates).[1] | Persons in Family/Household | Poverty Guideline | 300% of FPL | |-----------------------------|-------------------|--------------| | 1 | $15,060 | **$45,180** | | 2 | $20,440 | **$61,320** | | 3 | $25,820 | **$77,460** | | 4 | $31,200 | **$93,600** | | 5 | $36,580 | **$109,740** | | 6 | $41,960 | **$125,880** | *Add $5,380 per person for larger households at 300% FPL. Income includes all household members; provide proof like tax returns or pay stubs.[1][6] ## Insurance Requirements - **Uninsured or underinsured**: Eligible for free medicine if other criteria met.[2][3] - **Medicaid**: Claims often reimbursed; patients may qualify for PAP.[3][program details] - **Medicare Part D**: Potentially eligible, but confirm with program.[8] - **Commercial insurance**: Not eligible for PAP free medicine, but program reimburses nearly all claims.[program details][2] The program prioritizes those unable to afford costs and attests to financial need.[6] ## Step-by-Step Application Process 1. **Consult your doctor**: Ensure you have a valid prescription for ABRYSVO for an FDA-approved indication. 2. **Call Pfizer RxPathways**: Dial **(866) 744-3198** (or 1-844-989-PATH for general inquiries). A Medicine Access Counselor will screen eligibility.[program details][2][6] 3. **Submit enrollment**: Complete the form (mailed or discussed via phone). No online application; phone-based.[program details] 4. **Provide documents**: Proof of income (W-2, pay stub, tax return), proof of residency, prescription, and insurance status (if applicable).[6] 5. **Doctor involvement**: Your provider may need to confirm outpatient treatment and diagnosis.[2] 6. **Await approval**: Counselor guides through process. Application is straightforward via phone, tailored for patient ease.[program details] ## Timeline and Delivery Processing time varies; expect decisions within days to weeks, though not specified.[6] Once approved, ABRYSVO is **provided through insurance coverage or patient assistance**—reimbursed to pharmacy/provider or shipped as needed.[program details] No reauthorization typically needed for single-dose vaccine, but check for annual renewals if circumstances change.[3] ## Alternatives if Denied or Ineligible - **Biosimilar alternative**: Consider **AREXVY (GSK)**, another RSV vaccine; explore GSK's assistance programs.[program details] - **Other Pfizer options**: Bridge Program or copay assistance for insured (income varies).[8] - **General resources**: NeedyMeds, RxAssist, or state programs. Call 1-844-989-PATH for connections.[5][7] - **Reapply**: If income changes or upon re-enrollment periods (e.g., annual).[3] ## Important Disclaimer This guide is for informational purposes based on available program details as of latest data. Eligibility rules change; **always verify directly with Pfizer RxPathways at (866) 744-3198**.[1][2][6] Not medical advice—consult your doctor. Pfizer may require prior authorization or alternate assistance trials. Income tables approximate; use official FPL.[1] Word count: 942.

Program information last verified: March 30, 2026